{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:37:13Z","timestamp":1792888633297,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012737","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article provides a focused update to the clinical practice guideline on the treatment and management of people with COVID-19, developed by the Infectious Diseases Society of America. The guideline panel presents 9 updated recommendations on the use of nirmatrelvir\/ritonavir, remdesivir, and molnupiravir, in adults with mild to moderate COVID-19. The recommendations are based on evidence derived from a systematic literature review and adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. The panel also provides a section on how to apply these recommendations, including an algorithm on the selection of antivirals.<\/jats:p>","DOI":"10.1093\/cid\/ciaf680","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:43:14Z","timestamp":1771591394000},"page":"i1-i17","source":"Crossref","is-referenced-by-count":8,"title":["2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults"],"prefix":"10.1093","volume":"82","author":[{"given":"Amy Hirsch","family":"Shumaker","sequence":"first","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, VA Northeast Ohio Healthcare System , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5008-3128","authenticated-orcid":false,"given":"Adarsh","family":"Bhimraj","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Houston Methodist Hospital , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-0389","authenticated-orcid":false,"given":"Roger","family":"Bedimo","sequence":"additional","affiliation":[{"name":"Department of Medicine, UT Southwestern\/VA North Texas Health Care System , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Chi-Chung","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong , Pokfulam, Hong Kong Special Administrative Region ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara W","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S","family":"Daar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harbor-UCLA Medical Center , Torrance, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5888-1419","authenticated-orcid":false,"given":"David V","family":"Glidden","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, UCSF , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Shafer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University , Palo Alto, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis C","family":"Tien","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCSF\/VA San Francisco Health Care System , San Francisco, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R","family":"Baden","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cawcutt","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Nebraska Medical Center , Omaha, Nebraska ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-8708","authenticated-orcid":false,"given":"Kathleen","family":"Chiotos","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia\/University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Dzierba","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York University Grossman School of Medicine , New York City, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J","family":"Hardy","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Obstetrics and Gynecology, Brown University , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado School of Medicine , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y","family":"Kim","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"MacBrayne","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Children's Hospital Colorado , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg S","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Nadig","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari M","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Antimicrobial Stewardship Program and Division of Infectious Diseases, Boston Children's Hospital , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Pediatrics, Harvard Medical School , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-4569","authenticated-orcid":false,"given":"Laura","family":"Riley","sequence":"additional","affiliation":[{"name":"New York-Presbyterian Hospital\/Weill Cornell Medical Center , New York City, New York ,","place":["USA"]},{"name":"Department of Obstetrics and Gynecology, Weill Cornell Medicine , New York City, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-7786","authenticated-orcid":false,"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-7942","authenticated-orcid":false,"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-5274","authenticated-orcid":false,"given":"Zachary","family":"Willis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-3646","authenticated-orcid":false,"given":"Joshua","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loveless","sequence":"additional","affiliation":[{"name":"Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University, School of Medicine , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, VA Northeast Ohio Healthcare System , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh T","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Harvard Medical School , Boston, Massachusetts ,","place":["USA"]},{"name":"Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026082412172432100_ciaf680-B1","author":"U.S. Food and Drug Administration"},{"key":"2026082412172432100_ciaf680-B2","author":"Centers for Disease Control and Prevention"},{"key":"2026082412172432100_ciaf680-B3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","article-title":"Mortality risk among patients hospitalized primarily for COVID-19 during the Omicron and Delta variant pandemic periods\u2014United States, April 2020\u2013June 2022","volume":"71","author":"Adjei","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412172432100_ciaf680-B4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.15585\/mmwr.mm7339a2","article-title":"COVID-19-associated hospitalizations among U.S. adults aged \u226518 years\u2014COVID-NET, 12 states, October 2023\u2013April 2024","volume":"73","author":"Taylor","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412172432100_ciaf680-B5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"2026082412172432100_ciaf680-B6","doi-asserted-by":"crossref","first-page":"100747","DOI":"10.1016\/j.lanepe.2023.100747","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026082412172432100_ciaf680-B7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jamaoncol.2021.6199","article-title":"Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid Registry","volume":"8","author":"Pinato","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026082412172432100_ciaf680-B8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/v15010175","article-title":"Risk factors of severe COVID-19: a review of host, viral and environmental factors","volume":"15","author":"Zsichla","year":"2023","journal-title":"Viruses"},{"key":"2026082412172432100_ciaf680-B9","doi-asserted-by":"crossref","first-page":"e2129639","DOI":"10.1001\/jamanetworkopen.2021.29639","article-title":"Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19","volume":"4","author":"Izadi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026082412172432100_ciaf680-B10","author":"U.S. Food and Drug Administration"},{"key":"2026082412172432100_ciaf680-B11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B12","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibitis RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"2026082412172432100_ciaf680-B13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe COVID-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cid\/ciad409","article-title":"Impact of molnupiravir treatment on patient-reported COVID-19 symptoms in the Phase 3 MOVe-OUT trial: a randomized, placebo-controlled trial","volume":"77","author":"Guan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026082412172432100_ciaf680-B15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendation","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026082412172432100_ciaf680-B16","author":"Infectious Diseases Society of America"},{"key":"2026082412172432100_ciaf680-B17","first-page":"100694","article-title":"Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study","volume":"33","author":"Liu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2026082412172432100_ciaf680-B18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJMoa2309003","article-title":"Nirmatrelvir for vaccinated or unvaccinated adult outpatients with COVID-19","volume":"390","author":"Hammond","year":"2024","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S1473-3099(25)00093-3","article-title":"Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"25","author":"RECOVERY Collaborative Group","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026082412172432100_ciaf680-B20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciae551","article-title":"Alleviation of COVID-19 Symptoms and reduction in healthcare utilization among high-risk patients treated with nirmatrelvir\/ritonavir (NMV\/R): a phase 3 randomized trial","volume":"80","author":"Hammond","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026082412172432100_ciaf680-B21","author":"Paxlovid"},{"key":"2026082412172432100_ciaf680-B22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2204919","article-title":"Nirmatrelvir use and severe COVID-19 outcomes during the Omicron surge","volume":"387","author":"Arbel","year":"2022","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","article-title":"Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the Omicron wave in Hong Kong: an observational study","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"2026082412172432100_ciaf680-B24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMc2205944","article-title":"Nirmatrelvir-ritonavir and viral load rebound in COVID-19","volume":"387","author":"Anderson","year":"2022","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B25","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1093\/cid\/ciac481","article-title":"Rebound phenomenon after nirmatrelvir\/ritonavir treatment of Coronavirus disease 2019 (COVID-19) in high-risk persons","volume":"76","author":"Ranganath","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026082412172432100_ciaf680-B26","doi-asserted-by":"publisher","author":"Wang","DOI":"10.1101\/2022.06.21.22276724"},{"key":"2026082412172432100_ciaf680-B27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(22)00873-8","article-title":"Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study","volume":"23","author":"Wong","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026082412172432100_ciaf680-B28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.15585\/mmwr.mm7125e2","article-title":"Hospitalization and emergency department encounters for COVID-19 after Paxlovid treatment\u2014California, December 2021\u2013May 2022","volume":"71","author":"Malden","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412172432100_ciaf680-B29","author":"U.S. Food and Drug Administration"},{"key":"2026082412172432100_ciaf680-B30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.15585\/mmwr.mm7251a2","article-title":"Evaluation of SARS-CoV-2 RNA rebound after nirmatrelvir\/ritonavir treatment in randomized, double-blind, placebo-controlled trials\u2014United States and international sites, 2021\u20132022","volume":"72","author":"Harrington","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412172432100_ciaf680-B31","doi-asserted-by":"crossref","first-page":"e2238867","DOI":"10.1001\/jamanetworkopen.2022.38867","article-title":"Recurrence of symptoms following a 2-day symptom free period in patients with COVID-19","volume":"5","author":"Smith","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026082412172432100_ciaf680-B32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/cid\/ciae333","article-title":"Efficacy and safety of remdesivir in people with impaired kidney function hospitalized for COVID-19 pneumonia: a randomized clinical trial","volume":"79","author":"Sise","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026082412172432100_ciaf680-B34","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"2026082412172432100_ciaf680-B35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19\u2014interim WHO SOLIDARITY trial results","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B36","doi-asserted-by":"crossref","first-page":"EVIDoa2100044","DOI":"10.1056\/EVIDoa2100044","article-title":"Randomized trial of molnupiravir or placebo in patients hospitalized with COVID-19","volume":"1","author":"Arribas","year":"2022","journal-title":"NEJM Evid"},{"key":"2026082412172432100_ciaf680-B37","doi-asserted-by":"crossref","first-page":"EVIDoa2100043","DOI":"10.1056\/EVIDoa2100043","article-title":"Phase 2\/3 trial of molnupiravir for treatment of COVID-19 in nonhospitalized adults","volume":"1","author":"Caraco","year":"2022","journal-title":"NEJM Evid"},{"key":"2026082412172432100_ciaf680-B38","doi-asserted-by":"crossref","first-page":"eabl7430","DOI":"10.1126\/scitranslmed.abl7430","article-title":"A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus","volume":"14","author":"Fischer","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026082412172432100_ciaf680-B39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2021","journal-title":"N Engl J Med"},{"key":"2026082412172432100_ciaf680-B40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(22)00644-2","article-title":"Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial","volume":"23","author":"Khoo","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026082412172432100_ciaf680-B41","first-page":"e31508","article-title":"Efficacy and safety of molnupiravir in mild COVID-19 patients in India","volume":"14","author":"Sinha","year":"2022","journal-title":"Cureus"},{"key":"2026082412172432100_ciaf680-B42","doi-asserted-by":"crossref","first-page":"939573","DOI":"10.3389\/fphar.2022.939573","article-title":"Antiviral efficacy and safety of molnupiravir against Omicron variant infection: a randomized controlled clinical trial","volume":"13","author":"Zou","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026082412172432100_ciaf680-B43","author":"U.S. Food and Drug Administration"},{"key":"2026082412172432100_ciaf680-B44","author":"Lagevrio FAQs"},{"key":"2026082412172432100_ciaf680-B45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.15585\/mmwr.mm7303a2","article-title":"Underuse of antiviral drugs to prevent progression to severe COVID-19\u2014Veterans Health Administration, March\u2013September 2022","volume":"73","author":"Monach","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026082412172432100_ciaf680-B46","doi-asserted-by":"crossref","first-page":"e235044","DOI":"10.1001\/jamahealthforum.2023.5044","article-title":"Clinical risk and outpatient therapy utilization for COVID-19 in the Medicare population","volume":"5","author":"Wilcock","year":"2024","journal-title":"JAMA Health Forum"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf680\/67713803\/ciaf680.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i1\/67713803\/ciaf680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_3\/i1\/67713803\/ciaf680.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:17:32Z","timestamp":1787588252000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_3\/i1\/8571315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":46,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf680","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,15]]},"published":{"date-parts":[[2026,4,1]]}}}